Avicenna Journal of Medical Biotechnology

Avicenna Journal of Medical Biotechnology

Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19

Letter to Editor

Authors
Hoda Keshmiri Neghab 1
Seyedeh Sara Azadeh 2
Mohammad Hasan Soheilifar 3
Fariba Dashtestani 4
1 Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran; Department of Photo Healing and Regeneration, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran
2 Department of Biology, Science and Research branch, Islamic Azad University, Tehran, Iran
3 Department of Medical Laser, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran
4 Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
  1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506.
  2. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579(7798):265-269.
  3. Habibzadeh P, Stoneman EK. The novel coronavirus: A bird’s eye view. Int J Occup Environ Med 2020;11(2):65-71.
  4. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive CareMed 2020;46(4):586-590.
  5. Huang L, Sexton DJ, Skogerson K, Devlin M, Smith R, Sanyal I, et al. Novel peptides inhibitors of angiotensin converting enzyme 2. J Biol Chem 2003;278(18):15532-15540.
  6. Koren G, King S, Knowles S, Phillips E. Ribavirin in the treatment of SARS: A new trick for an old drug? CMAJ. 2003;168(10):1289-1292.
  7. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nat Med 2005;11(8):875-879.
  8. Gao Y, Kraft JC, Yu D, Ho RJ. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy. Eur J Pharm Biopharm 2019;138:75-91.
  9. Zarei-Ghobadi M, Mozhgani SH, Dashtestani F, Yadegari A, Hakimian F, Norouzi M, et al. A genosensor for detection of HTLV-I based on photoluminescence quenching of fluorescent carbon dots in presence of iron magnetic nanoparticle-capped Au. Scientific Reports 2018;8(1):1-8.
  10. Zhu B, Liu GL, Ling F, Wang GX. Carbon nanotube-based nanocarrier loaded with ribavirin against grass carp reovirus. Antiviral Res 2015;118:29-38.
  11. Cojocaru FD, Botezat D, Gardikiotis I, Uritu CM, Dodi G, Trandafir L, et al. Nanomaterials designed for antiviral drug delivery transport across biological barriers. Pharmaceutics 2020;12(2):171.
  12. Ventola CL. Progress in nanomedicine: approved and investigational nanodrugs. PT 2017;42(12):742-755.
  13. Pedersen KB, Sriramula S, Chhabra KH, Xia H, Lazartigues E. Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays. Am J Physiol Regul Integr Comp Physiol 2011;301(5):R1293-1299.
  14. Locatelli E, Comes Franchini M. Biodegradable PLGA-b-PEG polymeric nanopajmb_articles: synthesis, properties, and nanomedical applications as drug delivery system. J Nanopart Res 2012;14(12):1316.
Avicenna Journal of Medical Biotechnology
Volume 12, Issue 4
Autumn 2020
Pages 255-256